CYP3A4 and hepatocellular carcinoma: 3.2 Epimedium suppressed CYP3A4 mRNA expression and reduced dexamethasone enhancement of CYP3A4 mRNA expression without cytotoxicity in a human liver carcinoma cell line (HepG2)